Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence

Introduction: Limited data on the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCW) are publicly available. In this study we sought to determine the seroprevalence of SARS-CoV-2 in a population of HCWs in a pediatric emergency department (E...

Full description

Bibliographic Details
Main Authors: Theodore W. Heyming, Terence Sanger, Aprille Tongol, John Schomberg, Kellie Bacon, Bryan Lara
Format: Article
Language:English
Published: eScholarship Publishing, University of California 2021-05-01
Series:Western Journal of Emergency Medicine
Online Access:https://escholarship.org/uc/item/4rv6721f
_version_ 1818743574482649088
author Theodore W. Heyming
Terence Sanger
Aprille Tongol
John Schomberg
Kellie Bacon
Bryan Lara
author_facet Theodore W. Heyming
Terence Sanger
Aprille Tongol
John Schomberg
Kellie Bacon
Bryan Lara
author_sort Theodore W. Heyming
collection DOAJ
description Introduction: Limited data on the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCW) are publicly available. In this study we sought to determine the seroprevalence of SARS-CoV-2 in a population of HCWs in a pediatric emergency department (ED). Methods: We conducted this observational cohort study from April 14–May 13, 2020 in a pediatric ED in Orange County, CA. Asymptomatic HCW ≥18 years of age were included in the study. Blood samples were obtained by fingerstick at the start of each shift. The inter-sampling interval was ≤96 hours. The primary outcome was positive seroprevalence of SARS-CoV-2 as determined with an antibody fast detection kit (Colloidal Gold, Superbio, Timisoara, Romania) for the SARS-CoV-2 immunoglobulin M/immunoglobulin G (IgM/IgG) antibody. Results: A total of 143 HCWs participated in the study. Overall SARS-CoV-2 seroprevalence was 10.5% (n = 15). Positive seroprevalence was classified as IgG only (4.9%), IgM+IgG (3.5%), or IgM only (2.1%). SARS-CoV-2 was detected by reverse transcription polymerase chain reaction RT-PCR in 0.7% of the overall study population (n = 1). Samples obtained on Day 1 indicated seropositivity in 4.2% of the study population (n = 6). Subsequent seroconversion occurred in 6.3% of participants (n = 9). The rate of seroconversion was linear with a rate of approximately one new case every two days, starting at Day 9 of the study. Conclusion: We observed a linear rate of seroconversion to SARS-CoV-2–positive status among asymptomatic HCWs who underwent daily symptom surveys and temperature screens in an environment with universal source control. Rapid antibody testing may be useful for screening for SARS-CoV-2 seropositivity in high-risk populations, such as HCWs in the ED.
first_indexed 2024-12-18T02:30:35Z
format Article
id doaj.art-7db54fa2116d4cdb9c00ca18d21b5420
institution Directory Open Access Journal
issn 1936-9018
language English
last_indexed 2024-12-18T02:30:35Z
publishDate 2021-05-01
publisher eScholarship Publishing, University of California
record_format Article
series Western Journal of Emergency Medicine
spelling doaj.art-7db54fa2116d4cdb9c00ca18d21b54202022-12-21T21:23:55ZengeScholarship Publishing, University of CaliforniaWestern Journal of Emergency Medicine1936-90182021-05-0122310.5811/westjem.2021.1.50058wjem-22-565Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 SeroprevalenceTheodore W. Heyming0Terence Sanger1Aprille Tongol2John Schomberg3Kellie Bacon4Bryan Lara5Children’s Hospital of Orange County, Department of Emergency Medicine, Orange, CaliforniaUniversity of California, Irvine, Department of Electrical Engineering and Computer Science, Irvine, CaliforniaChildren’s Hospital of Orange County, Research Institute, Orange, CaliforniaChildren’s Hospital of Orange County, Department of Nursing, Orange, CaliforniaChildren’s Hospital of Orange County, Research Institute, Orange, CaliforniaChildren’s Hospital of Orange County, Research Institute, Orange, CaliforniaIntroduction: Limited data on the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among healthcare workers (HCW) are publicly available. In this study we sought to determine the seroprevalence of SARS-CoV-2 in a population of HCWs in a pediatric emergency department (ED). Methods: We conducted this observational cohort study from April 14–May 13, 2020 in a pediatric ED in Orange County, CA. Asymptomatic HCW ≥18 years of age were included in the study. Blood samples were obtained by fingerstick at the start of each shift. The inter-sampling interval was ≤96 hours. The primary outcome was positive seroprevalence of SARS-CoV-2 as determined with an antibody fast detection kit (Colloidal Gold, Superbio, Timisoara, Romania) for the SARS-CoV-2 immunoglobulin M/immunoglobulin G (IgM/IgG) antibody. Results: A total of 143 HCWs participated in the study. Overall SARS-CoV-2 seroprevalence was 10.5% (n = 15). Positive seroprevalence was classified as IgG only (4.9%), IgM+IgG (3.5%), or IgM only (2.1%). SARS-CoV-2 was detected by reverse transcription polymerase chain reaction RT-PCR in 0.7% of the overall study population (n = 1). Samples obtained on Day 1 indicated seropositivity in 4.2% of the study population (n = 6). Subsequent seroconversion occurred in 6.3% of participants (n = 9). The rate of seroconversion was linear with a rate of approximately one new case every two days, starting at Day 9 of the study. Conclusion: We observed a linear rate of seroconversion to SARS-CoV-2–positive status among asymptomatic HCWs who underwent daily symptom surveys and temperature screens in an environment with universal source control. Rapid antibody testing may be useful for screening for SARS-CoV-2 seropositivity in high-risk populations, such as HCWs in the ED.https://escholarship.org/uc/item/4rv6721f
spellingShingle Theodore W. Heyming
Terence Sanger
Aprille Tongol
John Schomberg
Kellie Bacon
Bryan Lara
Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
Western Journal of Emergency Medicine
title Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
title_full Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
title_fullStr Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
title_full_unstemmed Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
title_short Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence
title_sort provider antibody serology study of virus in the emergency room passover study special population covid 19 seroprevalence
url https://escholarship.org/uc/item/4rv6721f
work_keys_str_mv AT theodorewheyming providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence
AT terencesanger providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence
AT aprilletongol providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence
AT johnschomberg providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence
AT kelliebacon providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence
AT bryanlara providerantibodyserologystudyofvirusintheemergencyroompassoverstudyspecialpopulationcovid19seroprevalence